M

Moleculin Biotech
D

MBRX

2.12000
USD
0.08
(3.92%)
مغلق
حجم التداول
7,352
الربح لكل سهم
-5
العائد الربحي
-
P/E
-0
حجم السوق
6,527,965
أصول ذات صلة المقالات

العنوان: Moleculin Biotech Inc

القطاع: Healthcare
الصناعة: Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.